{"name": "Pacira Pharmaceuticals",
 "permalink": "pacira-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/pacira-pharmaceuticals",
 "homepage_url": "http://www.pacira.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 1989,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "858-625-2424",
 "description": "Injectable pharmaceutical products",
 "created_at": "Tue Jan 04 07:01:05 UTC 2011",
 "updated_at": "Mon Feb 11 05:36:14 UTC 2013",
 "overview": "\u003Cp\u003EPacira Pharmaceuticals Inc. operates as a pharmaceutical company which engages in the development and manufacturing of injectable pharmaceutical products. Pacira Pharmaceuticals Inc. was formerly known as DepoTech Corp. was formerly as SkyePharma Inc. and changed its name to Pacira Pharmaceuticals Inc. in June, 2007. The company was founded in 1989 and is based in San Diego, California. Pacira Pharmaceuticals Inc. operates as a subsidiary of Pacira, Inc.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       63],
      "assets/images/resized/0011/6153/116153v2-max-150x150.jpg"],
     [[208,
       88],
      "assets/images/resized/0011/6153/116153v2-max-250x250.jpg"],
     [[208,
       88],
      "assets/images/resized/0011/6153/116153v2-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "David",
      "last_name": "Stack",
      "permalink": "david-stack",
      "image":
       {"available_sizes":
         [[[84,
            115],
           "assets/images/resized/0023/5006/235006v1-max-150x150.jpg"],
          [[84,
            115],
           "assets/images/resized/0023/5006/235006v1-max-250x250.jpg"],
          [[84,
            115],
           "assets/images/resized/0023/5006/235006v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Vice President, Human Resources",
    "person":
     {"first_name": "Paul",
      "last_name": "R. Ellwood",
      "permalink": "paul-r-ellwood",
      "image":
       {"available_sizes":
         [[[84,
            115],
           "assets/images/resized/0023/5007/235007v1-max-150x150.jpg"],
          [[84,
            115],
           "assets/images/resized/0023/5007/235007v1-max-250x250.jpg"],
          [[84,
            115],
           "assets/images/resized/0023/5007/235007v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "10450 Science Center Drive",
    "address2": "",
    "zip_code": "92037",
    "city": "San Diego",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "IPO Registrant Pacira Taps Investors As Pain Drug Advances",
    "stoned_year": 2011,
    "stoned_month": 1,
    "stoned_day": 4,
    "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32\u0026aid=DJFVW00020110103e714000dx\u0026r=Rss\u0026s=DJFVW",
    "source_text": "",
    "source_description": "IPO Registrant Pacira Taps Investors As Pain Drug Advances",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Pacira Pharmaceuticals",
      "permalink": "pacira-pharmaceuticals"}},
   {"description": "Pacira Pharmaceuticals, Inc. Announces Pricing of $110 Million Private Offering of Convertible Senior Notes",
    "stoned_year": 2013,
    "stoned_month": 1,
    "stoned_day": 17,
    "source_url": "http://investor.pacira.com/phoenix.zhtml?c=220759\u0026p=irol-newsArticle\u0026ID=1775540\u0026highlight=",
    "source_text": "",
    "source_description": "Pacira Pharmaceuticals, Inc. Announces Pricing of $110 Million Private Offering of Convertible Senior Notes",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Pacira Pharmaceuticals",
      "permalink": "pacira-pharmaceuticals"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[143,
        150],
       "assets/images/resized/0023/5005/235005v1-max-150x150.jpg"],
      [[239,
        250],
       "assets/images/resized/0023/5005/235005v1-max-250x250.jpg"],
      [[430,
        450],
       "assets/images/resized/0023/5005/235005v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}